Skip to main content Accessibility help
×
Home

Tonsil cancer treated with radiotherapy during a pregnancy: a case report

  • Wendy Jazmin Martinez Pineda (a1), Angel Luis Calva Espinosa (a1), Alicia Guillermina Gonzalez Noguez, Carlos Osorio Solis (a1) and Alvar Jose Vacio Olguin (a1)...

Abstract

Introduction:

Cancer during pregnancy has an incidence of 1/1,000, and when diagnosed, the most common ones are breast cancer (1/10,000), Hodgkin’s lymphoma (1/6,000), and head and neck cancer (1/10,000). If a diagnosis is made during pregnancy, the treatment cannot wait until delivery, and there is concern about the effects that radiotherapy may have on the foetus. The multidisciplinary group has to assess and ethically make decisions with regard to the mother and foetus.

Clinical case:

A 35-year-old female, a carrier of Behcet’s disease, underwent 5 years of treatment with hydroxychloroquine, prednisone and low-molecular-weight heparin (the patient being a carrier of Behcet’s disease, there is a high risk for cancer of the oral cavity and oropharynx with an HR of 2·11, so the cancer could be related to the tonsil). The patient’s oncological situation started on December 2017 with a volume increase in preauricular, parotid and right mandibular angle, with a progressive growth. At this time, the foetus was of 17·5 weeks of gestation. An oral cavity tumour that invaded the right retromolar triangle was observed, and upon biopsy, a basaloid squamous cell carcinoma was diagnosed.

Radiotherapy treatment was started at 22 weeks of gestation; intensity-modulated radiation therapy (IMRT) was planned with a dose of 69·96 Gy to the primary tumour and 59·4 Gy to ganglion levels II, III and IV, bilaterally in 33 fractions. At fraction 27 a significant decrease in tumour volume was noted, so adaptive radiotherapy was performed to complete the treatment. Currently the patient has no clinical evidence of tumour pathology.

Discussion:

The risk of radiation exposure in pregnant women (after 20 weeks of gestation), being treated for cancers of the tonsil, reaching the foetus is minimal, with a reduced risk of a few or no effects.

Conclusions:

Radiotherapy in tonsil cancer has been shown to be effective in combination with chemotherapy for local control of the disease. In the case of this pregnant patient, radiotherapy, as the only modality, provided local control and little exposure of radiation to the foetus.

Copyright

Corresponding author

Author for correspondence: Wendy Jazmin Martinez Pineda, Instituto Mexicano del Seguro Social, Cuauhtemoc, Ciudad de Mexico, Mexico. E-mails: alvar_vacio@yahoo.com.mx; alvarvacio@gmail.com

References

Hide All
1.Kal, H B, Struikmans, H.Radiotherapy during pregnancy: fact and fiction. Lancet Oncol 2005; 6: 328333. doi: 10.1016/S1470-2045(05)70169-8.
2.Latorre Travis, E.Radiobiología médica. Embrión y feto. Madrid, Spain: Editorial AC, 1979, 135147.
3.De Santis, M, Straface, G.Effect of Radiation on the Embryo and Fetus. Human Radiation Injury. Philadelphia, PA: Lippincott Williams & Wilkins, 2011, Chapter 15, 13001345.
4.Latorre Travis, E.Radiobiología médica. Radiobiología Clínica 2. Madrid, Spain: Editorial AC, 1979, 200202.
5.Rusell, L B, Montgomery, C S.Radiation sensitivity differences with cell division cycles during mouse cleavage. Int J Radiat Biol 1966; 10:151152. doi: 10.1080/09553006614550201.
6.Yashimoto, Y, Mabuchi, K.Mortality and cancer risk among offspring (F1) of atomic bomb survivors. J Radiat Res (Tokio) 1991; 32: 294300. doi: 10.1269/jrr.32.Suppl_1.294.
7.Mole, R H.Detriment in human after irradiation in utero. Int J Radiat Biol 1991; 60: 561564.
8.Latorre Travis, E.Radiobiología médica. Los riesgos en el radiodiagnóstico. Madrid, Spain: Editorial AC, 1979, 173178.
9.Nuyttens, J J, Prado, K L, Jenrette, J M, et al. Fetal dose during radiotherapy: clinical implementation and review of the literatura. Cancer/Radiothér 2002; 6: 353355. doi: 10.1016/S1278-3218(02)00249-4
10.Podgorsak, M B, Meiler, R J, Kowal, H, et al. Technical management of a pregnant patient undergoing radiation therapy to the head and neck. Med Dosim 1999; 24: 121128. doi: 10.1016/S0958-3947(99)00010-2
11.Bray, F, Jacques Ferlay, M E, Soerjomataram, I, et al. Globocan cancer statistic 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2018; 68: 94424. doi: 10.3322/caac.21492.
12.Sea Jung, N A, Min Ji, K, Dong Soo, Y, et al. Cancer risk in patients with Behcet disease: a nationwide population-based dynamic cohort study from Korea. J Am Acad Dermatol 2018; 78: 464470. doi: 10.1016/j.jaad.2017.09.035.
13.Wang, L H, Wang, W M, Shen-Min, H, et al. Risk of overall and site - specific cancers in Behcet disease: a nationwide population - based study in Taiwan. J Rheum. 2015; 42: 879884. doi: 10.3899/jrheum.140770.
14.Stessin, A M, Ozyigit, G, Clifford Chao, K S.Practical Essentials of Intensity Modulated Radiation Therapy. 3rd Edition. Philadelphia, PA: Lippincott, 2015. Chapter 8, 171181.

Keywords

Tonsil cancer treated with radiotherapy during a pregnancy: a case report

  • Wendy Jazmin Martinez Pineda (a1), Angel Luis Calva Espinosa (a1), Alicia Guillermina Gonzalez Noguez, Carlos Osorio Solis (a1) and Alvar Jose Vacio Olguin (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.